Key result
Levosimendan increased cardiac index from 2.14 at baseline to 2.67 l/min/m2 at 4 hours in patients with low cardiac output following cardiac surgery.
Why the study?
Does levosimendan improve hemodynamics in patients with low cardiac output status resistant to conventional inotropes following cardiac surgery?
Observational (n=9)
Does levosimendan improve hemodynamics in patients with low cardiac output status resistant to conventional inotropes following cardiac surgery?
Answers are grounded in this paper and cite their sources.
Levosimendan significantly improves cardiac index and reduces systemic vascular resistance in post-cardiac surgery patients with refractory low cardiac output, allowing for weaning of other supports.
The efficacy of levosimendan treatment for a low cardiac output status following cardiac surgery has not been established. Here, we review our initial experiences of the perioperative use of levosimendan. This study is a retrospective uncontrolled trial. Nine patients who underwent cardiac surgery, and developed a low cardiac output status resistant to conventional inotropic support, were given levosimendan. The mean preoperative ejection fraction was 35.2+/-3.4%. All patients were on concomitant inotropic agents and had previously undergone intra-aortic balloon pumping. Cardiac index increased immediately from 2.14+/-0.33 l/min/m(2) at baseline to 2.41+/-0.31 (P=0.02) at 1 h, rising to 2.67+/-0.43 (P<0.001) at 4 h after the loading dose was started. Similarly, the systemic vascular resistance index decreased from 2350+/-525 dynes/s/cm(-5)/m(2) at baseline to 1774+/-360 (P=0.002) at 4 h. In the case of all but one of the patients, either the dose of the concomitant inotropic support or the balloon pumping could be weaned down within 24 h after completion of the levosimendan infusion. No withdrawal of levosimendan was required. Levosimendan could constitute a new therapeutic option for postoperative low cardiac output.
No takes yet. Share an insight, caveat, or question.
Yoshiyuki Tokuda (2006) conducted an observational in Low cardiac output status following cardiac surgery (n=9). Levosimendan vs. Baseline (pre-treatment) was evaluated on Cardiac index at 4 hours (p=<0.001). Levosimendan increased cardiac index from 2.14 at baseline to 2.67 l/min/m2 at 4 hours in patients with low cardiac output following cardiac surgery.
Synapse has enriched 10 related papers. Consider them for comparative context: